-
1
-
-
17844406362
-
Making the transition from oral to insulin therapy
-
Riddle MC Making the transition from oral to insulin therapy. Am J Med. 2005 ; 118 (suppl 5A). 14S - 20S.
-
(2005)
Am J Med.
, vol.118
-
-
Riddle, M.C.1
-
2
-
-
29144453326
-
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
-
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group
-
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005 ; 353: 2643-2653.
-
(2005)
N Engl J Med.
, vol.353
, pp. 2643-2653
-
-
-
3
-
-
14744286020
-
Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus: Can it offer both cardiovascular protection and beta-cell preservation?
-
Gerstein HC, Rosenstock J. Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus: can it offer both cardiovascular protection and beta-cell preservation? Endocrinol Metab Clin North Am. 2005 ; 34: 137-154.
-
(2005)
Endocrinol Metab Clin North Am
, vol.34
, pp. 137-154
-
-
Gerstein, H.C.1
Rosenstock, J.2
-
4
-
-
33746588255
-
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy
-
Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2006 ; 29: 1963-1972.
-
(2006)
Diabetes Care.
, vol.29
, pp. 1963-1972
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
5
-
-
33748442464
-
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
-
Blonde L., Klein EJ, Han J., et al. Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. Diabetes Obes Metab. 2006 ; 8: 436-447.
-
(2006)
Diabetes Obes Metab
, vol.8
, pp. 436-447
-
-
Blonde, L.1
Klein, E.J.2
Han, J.3
-
6
-
-
26944477362
-
Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG. GWAA Study Group. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: A randomized trial
-
Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG. GWAA Study Group. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med. 2005 ; 143: 559-569.
-
(2005)
Ann Intern Med.
, vol.143
, pp. 559-569
-
-
Heine, R.J.1
Van2
-
7
-
-
0042166232
-
Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA1c
-
Monnier L., Lapinski H., Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care. 2003 ; 26: 881-885.
-
(2003)
Diabetes Care.
, vol.26
, pp. 881-885
-
-
Monnier, L.1
Lapinski, H.2
Colette, C.3
-
8
-
-
25644457629
-
Psychological insulin resistance in patients with type 2 diabetes: The scope of the problem
-
Polonsky WH, Fisher L., Guzman S., Villa-Caballero L., Edelman SV Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005 ; 28: 2543-2545.
-
(2005)
Diabetes Care
, vol.28
, pp. 2543-2545
-
-
Polonsky, W.H.1
Fisher, L.2
Guzman, S.3
Villa-Caballero, L.4
Edelman, S.V.5
-
9
-
-
13144283137
-
What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes
-
Polonsky WH, Jackson RA What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes. 2004 ; 22: 147-150.
-
(2004)
Clin Diabetes
, vol.22
, pp. 147-150
-
-
Polonsky, W.H.1
Jackson, R.A.2
-
10
-
-
33644798145
-
On behalf of the International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
-
Peyrot M., Rubin RR, Lauritzen T., et al, on behalf of the International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005 ; 28: 2673-2679.
-
(2005)
Diabetes Care.
, vol.28
, pp. 2673-2679
-
-
Peyrot, M.1
Rubin, R.R.2
Lauritzen, T.3
-
11
-
-
33644961570
-
FlexPen: Addressing issues of confidence and convenience in insulin delivery
-
Korytkowski M., Niskanen L., Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther. 2005 ; 27 (suppl 2). S89 - S100.
-
(2005)
Clin Ther.
, vol.27
, Issue.2
-
-
Korytkowski, M.1
Niskanen, L.2
Asakura, T.3
-
12
-
-
2542456983
-
Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes
-
Rosenstock J., Cappelleri JC, Bolinder B., Gerber RA Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care. 2004 ; 27: 1318-1323.
-
(2004)
Diabetes Care.
, vol.27
, pp. 1318-1323
-
-
Rosenstock, J.1
Cappelleri, J.C.2
Bolinder, B.3
Gerber, R.A.4
-
13
-
-
29144499379
-
Developing a quality measure for clinical inertia in diabetes care
-
Berlowitz DR, Ash AS, Glickman M., et al. Developing a quality measure for clinical inertia in diabetes care. Health Serv Res. 2005 ; 40 (6 pt 1). 1836-1853.
-
(2005)
Health Serv Res.
, vol.40
, Issue.6
, pp. 1836-1853
-
-
Berlowitz, D.R.1
Ash, A.S.2
Glickman, M.3
-
14
-
-
3042714557
-
The burden of treatment failure in type 2 diabetes
-
Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care. 2004 ; 27: 1535-1540.
-
(2004)
Diabetes Care
, vol.27
, pp. 1535-1540
-
-
Brown, J.B.1
Nichols, G.A.2
Perry, A.3
-
15
-
-
0242269000
-
The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
-
on behalf of the Insulin Glargine 4002 Study Investigators
-
Riddle MC, Rosenstock J., Gerich J., on behalf of the Insulin Glargine 4002 Study Investigators. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003 ; 26: 3080-3086.
-
(2003)
Diabetes Care.
, vol.26
, pp. 3080-3086
-
-
Riddle, M.C.1
Rosenstock, J.2
Gerich, J.3
-
16
-
-
0004100996
-
Medical management of type 2 diabetes
-
4th ed, Alexandria, Va: American Diabetes Association;
-
Zimmerman BR, ed. Medical Management of Type 2 Diabetes 4 th ed, Clinical Education Series. Alexandria, Va: American Diabetes Association ; 1998.
-
(1998)
Clinical Education Series
-
-
Zimmerman, B.R.1
-
17
-
-
0842330643
-
Timely initiation of basal insulin
-
Riddle MC Timely initiation of basal insulin. Am J Med. 2004 ; 116 (suppl 3A). 3S - 9S.
-
(2004)
Am J Med.
, vol.116
-
-
Riddle, M.C.1
-
18
-
-
0002883814
-
-
4th ed. San Diego, Calif: Torrey Pines Press;
-
Walsh J., Roberts R. Pumping Insulin. 4 th ed. San Diego, Calif: Torrey Pines Press ; 2006.
-
(2006)
Pumping Insulin
-
-
Walsh, J.1
Roberts, R.2
|